Novel Technique for Fluorescence Tomography of Tumors in Living Animals

Fluorescent molecules - i.e. substances which can be stimulated to emit light - are extremely valuable tools in biological research and medical diagnosis. Fluorescence can be used for instance to analyze the regulation and expression of genes, to locate proteins in cells and tissues, to follow metabolic pathways and to study the location and migration of cells. Of particular importance is the combination of fluorescence imaging with novel techniques that allow tomographic three-dimensional visualization of objects in living organisms.

At the Helmholtz Zentrum München - German Research Center for Environmental Health together with the Technische Universität München an own institute is concerned with the development and refinement of such new technologies: the Institute for Biological and Medical Imaging headed by Professor Vasilis Ntziachristos.

The quality of optical imaging in tissues is naturally limited, since beyond a penetration depth of a few hundred micrometers the photons are massively scattered due to interactions with cell membranes and organelles which results in blurred images. In the latest issue of the journal Proceedings of the National Academy of Sciences Prof. Ntziachristos and his team, together with colleagues from the Harvard Medical School and the Massachusetts General Hospital in Boston, USA, report on the use of the so-called early arriving photons together with tomographic principles. Early photons are the first photons that arrive onto a photon detector after illumination of tissue by an ultra-short photon pulse and undergo less scattering in comparison to photons arriving at later times. Compared to continuous illumination measurements a combination of these less scattered photons with 360-degree illumination-detection resulted in sharper and more accurate images of mice under investigation.

With this technique, called 'Early Photon Tomography' (EPT), the scientists imaged lung tumors in living mice. For this purpose they injected a substance into to the animals, which normally does not fluoresce, but becomes fluorescent after contact with certain cysteine proteases such as cathepsins. The amount of these proteases is enriched in lung tumors which allows fluorescence imaging of the tumor tissue. Comparison with conventional x-ray tomography showed, that EPT is not only a very sensitive technique for imaging of lung tumors in living organisms, but also has the potential to reveal biochemical changes that reflect the progression of the disease, which could not be detected by conventional X-ray imaging.

While early-photons are typically associated with reduced signal available for image formation, the authors demonstrated that due to the wide-field implementation, EPT operates with very small reduction in average signal strength as in conventional tomographic methods operating using continuous light illumination. In this respect EPT is a practical method for significantly improving the performance of fluorescence tomography in animals over existing implementations. At present EPT is practicable only with small animals, but - as stated by the authors of the paper - further development of the equipment can allow niche applications of the technique also with larger organisms including humans.

Publication:
Niedre, M.J., de Kleine, R.H., Aikawa, E., Kirsch, D.G., Weissleder, R., Ntziachristos, V. (2008): Early photon tomography allows fluorescence detection of lung carcinomas and disease progression in mice in vivo. Proceedings of the National Academy of Sciences; Published online before print November 17, 2008, doi: 10.1073/pnas.0804798105

For further information, please visit:
http://www.helmholtz-muenchen.de/en/ibmi/

About Helmholtz Zentrum München
The Helmholtz Zentrum München is a research institution of the Federal Government and the State of Bavaria within the Helmholtz Association of German Research Centres, the largest scientific organisation in Germany.

The Helmholtz Association is a community of 15 scientific-technical and biological-medical research centres. These centres have been commissioned with pursuing long-term research goals on behalf of the state and society. The Association strives to gain insights and knowledge so that it can help to preserve and improve the foundations of human life. It does this by identifying and working on the grand challenges faced by society, science and industry. Helmholtz Centres perform top-class research in strategic programmes in six core fields: Energy, Earth and Environment, Health, Key Technologies, Structure of Matter, Transport and Space.

In future, the Helmholtz Zentrum München will be represented within the research field Health of the Helmholtz Association with both programs, Environmental Health und Systemic Analysis of Multifactorial Diseases, as well as in the field Earth and Environment with the Terrestrial Environment program.

Most Popular Now

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Commission Joins Forces with Venture Cap…

The Commission has launched a Trusted Investors Network bringing together a group of investors ready to co-invest in innovative deep-tech companies in Europe together with the EU. The Union's investment...

Why the NHS is Seeking to Make Media Ser…

Opinion Article by Dean Moody, Healthcare Services Director, Airwave Healthcare. Tim Kelsey and Martha Lane Fox called for WiFi to be made available free of charge throughout the NHS back in...

An AI-Powered Pipeline for Personalized …

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses...

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

AI could Transform How Hospitals Produce…

A pilot study led by researchers at University of California San Diego School of Medicine found that advanced artificial intelligence (AI) could potentially lead to easier, faster and more efficient...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...